Filing Analysis
🚪 Officer Departure
Filed May 12, 2026
🟡 MEDIUM
Dr. Roy Schoenberg, co-founder and Executive Vice Chairman of American Well Corporation, resigned from the Board of Directors effective May 6, 2026. The company stated the departure was to pursue a new employment opportunity and not due to any disagreements.
🚩 Red Flags
- Loss of a co-founder and long-term visionary leader after 20 years of service.
📋 Key Facts
- Dr. Roy Schoenberg resigned from the Board of Directors effective May 6, 2026.
- Schoenberg served as co-founder and Executive Vice Chairman for nearly twenty years.
- The resignation is attributed to a new employment opportunity.
- The filing states there were no disagreements regarding operations, policies, or procedures.
📢 Regulation FD Disclosure
Filed May 05, 2026
⚪ LOW
American Well Corporation (AMWL) announced its financial results for the first fiscal quarter ended March 31, 2026. The filing includes the earnings report as an exhibit and provides details for a corresponding investor conference call.
📋 Key Facts
- Financial results announced for the quarter ended March 31, 2026
- Earnings report furnished as Exhibit 99.1
- Conference call held on May 5, 2026, at 5 p.m. ET
- The filing was made under Item 2.02 (Results of Operations and Financial Condition)
🚪 Officer Departure
Filed Apr 02, 2026
⚪ LOW
Dr. Peter Slavin notified American Well Corporation of his resignation from the Board of Directors, effective as of the 2026 annual meeting of stockholders. The resignation is attributed to a career transition and not any disagreement with the company.
📋 Key Facts
- Dr. Peter Slavin resigned from the Board of Directors on April 1, 2026.
- The resignation will be effective on the date of the Company’s 2026 annual meeting of stockholders.
- Dr. Slavin served as a director for more than nine years.
- The reason for departure is a transition to a new role on the West Coast of the United States.
- The filing explicitly states there was no disagreement with the Company on any matter relating to operations, policies, or procedures.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.